3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Anatomic Stage III Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Renal Insufficiency, Chronic
1
Prostatic Neoplasms
1
Pleuropulmonary blastoma
1
Pain
1
Neuroblastoma
1
Melanoma
1
Leukemia, Hairy Cell
1
Ganglioneuroblastoma
1
Dupuytren Contracture
1
Carcinoma, Renal Cell
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
fludarabine
26
Azacitidine
24
venetoclax
23
Cyclophosphamide
21
Specimen Handling
19
fludarabine phosphate
17
Busulfan
15
Biopsy
15
Whole-Body Irradiation
14
Mycophenolic Acid
14
Melphalan
14
Tacrolimus
13
Cytarabine
13
Granulocyte Colony-Stimulating Factor
11
Decitabine
10
decitabine and cedazuridine drug combination
9
Stem Cell Transplantation
9
Sirolimus
9
Injections
9
Cyclosporine
9
Peripheral Blood Stem Cell Transplantation
8
Filgrastim
8
Thiotepa
7
ruxolitinib
5
X-Rays
5
Idarubicin
5
Methotrexate
4
Magnetic Resonance Spectroscopy
4
Cyclosporins
4
Cladribine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
High-Energy Shock Waves
×
90 days
×
Clear all
No trials found.